Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
Market Analysis and Insights: Global Postoperative Nausea and Vomiting (PONV) Market
The research report studies the Postoperative Nausea and Vomiting (PONV) market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Postoperative Nausea and Vomiting (PONV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Postoperative Nausea and Vomiting (PONV) Scope and Segment
The global Postoperative Nausea and Vomiting (PONV) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Postoperative Nausea and Vomiting (PONV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
NK-1 Receptor Antagonists
by Application, this report covers the following segments
Global Postoperative Nausea and Vomiting (PONV) market: regional analysis, the major regions covered in the report are:
Rest of Europe
Rest of Asia-Pacific
Middle East & Africa
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Postoperative Nausea and Vomiting (PONV) key players in this market include:
F. Hoffmann-La Roche